Evidence map›Paper›PMID 34390364›Full record

ArticleDiabetologia2021

Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study.

Sami Oikarinen, Lars Krogvold, Bjørn Edwin, Trond Buanes, Olle Korsgren, Jutta E Laiho, Maarit Oikarinen, Johnny Ludvigsson, Oskar Skog, Mahesh Anagandula and 3 more

Abstract read
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The immunology of type 1 diabetes.Nature reviews. Immunology · 2024
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sami OikarinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Sami.Oikarinen@tuni.fi.ORCID 0000-0003-3901-6774
Lars KrogvoldPaediatric Department, Oslo University Hospital, Oslo, Norway.
Bjørn EdwinPaediatric Department, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-3137-6225
Trond BuanesPaediatric Department, Oslo University Hospital, Oslo, Norway.
Olle KorsgrenDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Jutta E LaihoFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0002-5443-4651
Maarit OikarinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Johnny LudvigssonCrown Princess Victoria Children's Hospital and Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Oskar SkogDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Mahesh AnagandulaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Gun FriskDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Heikki HyötyFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0003-0370-4145
Knut Dahl-JørgensenPaediatric Department, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-6952-9899

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe Diabetes Virus Detection (DiViD) study is the first study to laparoscopically collect pancreatic tissue and purified pancreatic islets together with duodenal mucosa, serum, peripheral blood mononuclear cells (PBMCs) and stools from six live adult patients (age 24-35 years) with newly diagnosed type 1 diabetes. The presence of enterovirus (EV) in the pancreatic islets of these patients has previously been reported.

methodsIn the present study we used reverse transcription quantitative real-time PCR (RT-qPCR) and sequencing to characterise EV genomes present in different tissues to understand the nature of infection in these individuals.

resultsAll six patients were found to be EV-positive by RT-qPCR in at least one of the tested sample types. Four patients were EV-positive in purified islet culture medium, three in PBMCs, one in duodenal biopsy and two in stool, while serum was EV-negative in all individuals. Sequencing the 5' untranslated region of these EVs suggested that all but one belonged to enterovirus B species. One patient was EV-positive in all these sample types except for serum. Sequence analysis revealed that the virus strain present in the isolated islets of this patient was different from the strain found in other sample types. None of the islet-resident viruses could be isolated using EV-permissive cell lines. CONCLUSIONS/

interpretationEV RNA can be frequently detected in various tissues of patients with type 1 diabetes. At least in some patients, the EV strain in the pancreatic islets may represent a slowly replicating persisting virus.

Indexed as

AdultCell LineDiabetes Mellitus, Type 1EnterovirusEnterovirus InfectionsFecesFemaleHumansIslets of LangerhansMaleReal-Time Polymerase Chain ReactionRNA, ViralYoung AdultRNA, ViralEnterovirusLaparoscopyOrgansPancreasPersistent infectionRT-qPCRSequenceType 1 diabetesViral RNA

Identifiers

PMID34390364
PMCPMC8494699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.